Background and Aims Patients with inflammatory bowel disease (IBD) have an increased
risk of colorectal cancer (CRC). We performed a systematic review and meta-analysis to …

Restorative proctocolectomy with ileal pouch–anal anastomosis is an option for most
patients with ulcerative colitis or familial adenomatous polyposis who require colectomy …

This guideline is the second European Crohn's and Colitis Organisation [ECCO] evidence-
based consensus on inflammatory bowel disease [IBD] and malignancy, and is an update …

Inflammatory bowel diseases (IBD), comprising Crohn disease (CD) and ulcerative colitis
(UC), are chronic inflammatory conditions of the gastrointestinal tract driven by inappropriate …

Background: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily
of, but not restricted to, the gut. Association between IBD and cancer has been clearly …

METHODS: We conducted a national multicenter retrospective cohort study in patients with
either active or inactive pCD who received ustekinumab. In patients with active pCD at …

Inflammatory bowel diseases (IBD) and their treatments, particularly immunosuppressive
drugs, increase risk of infections and cancers. However, by promoting mucosal healing …

Background Inflammatory bowel disease (IBD) follows a heterogenous disease course and
predicting a patient's prognosis is challenging. There is a wide burden of illness in IBD and …

Background In a 6-year, multicenter, prospective nested case–control study, we aimed to
evaluate risk factors for incident cancer in inflammatory bowel disease (IBD), when …

Summary Background The management of Crohn's disease patients with perianal lesions
and anti‐TNF failure is challenging. Aims To assess the effectiveness of vedolizumab in …